{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:59:00Z","timestamp":1787241540106,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002669","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijrobp.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T02:11:36Z","timestamp":1637806296000},"page":"1177-1189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study"],"prefix":"10.1016","volume":"112","author":[{"given":"St\u00e9phanie","family":"Smet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"P\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Mahantshetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Sturdza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Segedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti","family":"Bruheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Van der Steen-Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Sundset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Van Limbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Tee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludy C.H.W.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Villafranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Tanderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Kirchheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.11.022_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0959-8049(01)00332-X","article-title":"Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions","volume":"38","author":"Servaes","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1634\/theoncologist.5-5-353","article-title":"Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition","volume":"5","author":"Curt","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpainsymman.2006.10.012","article-title":"The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer","volume":"34","author":"Gupta","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0004","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/annonc\/mdm057","article-title":"Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy","volume":"18","author":"Dagnelie","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/annonc\/mdw099","article-title":"Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: A meta-analysis involving 12 327 breast cancer survivors","volume":"27","author":"Abrahams","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0006","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.21671","article-title":"Fatigue in long-term breast carcinoma survivors: A longitudinal investigation","volume":"106","author":"Bower","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0007","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1200\/JCO.2001.19.14.3385","article-title":"Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors","volume":"19","author":"Cella","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0008","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1471-0528.2007.01445.x","article-title":"Chronic fatigue and its correlates in long-term Survivors of cervical cancer treated with radiotherapy","volume":"114","author":"Vistad","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0009","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/bjc.1998.600","article-title":"Fatigue and radiotherapy: (B) Experience in patients 9 months following treatment","volume":"78","author":"Smets","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11764-010-0145-7","article-title":"Predictors and course of chronic fatigue in long-term breast cancer survivors","volume":"4","author":"Reinertsen","year":"2010","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0011","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1200\/JCO.2011.34.6148","article-title":"Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study","volume":"30","author":"Goldstein","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0012","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2014Mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0013","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","article-title":"Health-related quality of Life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: An analysis from the EMBRACE study","volume":"94","author":"Kirchheiner","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0014","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/pcan.2009.61","article-title":"Fatigue in hormone-na\u00efve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy","volume":"13","author":"Kyrdalen","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.radonc.2012.04.007","article-title":"Impact of 3D image based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study","volume":"103","author":"Charra-Brunaud","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0016","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2018.05.016","article-title":"Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study","volume":"127","author":"Jensen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0019","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2018.05.002","article-title":"Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer","volume":"127","author":"Fokdal","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2014.01.032","article-title":"Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study","volume":"89","author":"Kirchheiner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.radonc.2018.03.009","article-title":"Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study","volume":"127","author":"Smet","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0022","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2018.03.026","article-title":"Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study","volume":"127","author":"Jamal","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0023","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0024","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2018.11.006","article-title":"Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: Results from the EMBRACE studies","volume":"103","author":"Fokdal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0026","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0027","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0028","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2020.10.006","article-title":"Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after radiochemotherapy with image guided adaptive brachytherapy in the EMBRACE I study","volume":"109","author":"Jensen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0029","doi-asserted-by":"crossref","first-page":"S1099","DOI":"10.1016\/S0167-8140(21)01986-1","article-title":"OC-1049: Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer","volume":"152","author":"Westerveld","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0032","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","article-title":"Cancer-related fatigue, version 2.2015","volume":"13","author":"Berger","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0033","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijrobp.2019.10.027","article-title":"Persistent, substantial, treatment-related symptoms after radiation therapy (LAPERS): a new method for longitudinal analysis of late morbidity-applied in the EMBRACE study","volume":"106","author":"Kirchheiner","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2020.08.044","article-title":"Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image guided adaptive brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study","volume":"109","author":"Vittrup","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2017.05.028","article-title":"A study of chronic fatigue in Norwegian cervical cancer survivors","volume":"146","author":"Steen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0036","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","article-title":"Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: A longitudinal study of the German Hodgkin Study Group","volume":"17","author":"Kreissl","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0037","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/0284186X.2015.1127417","article-title":"Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer","volume":"55","author":"Lilleby","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0038","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurpub\/ckp113","article-title":"Fatigue and chronic fatigue syndrome-like complaints in the general population","volume":"20","author":"van't Leven","year":"2010","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0039","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1200\/JCO.2011.36.4109","article-title":"Fatigue, inflammation, and \u03c9-3 and \u03c9-6 fatty acid intake among breast cancer survivors","volume":"30","author":"Alfano","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0040","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1002\/cncr.25294","article-title":"Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors","volume":"116","author":"Andrykowski","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0041","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.1997.15.1.223","article-title":"Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study","volume":"15","author":"Beard","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0042","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","article-title":"Screening, assessment, and management of fatigue in adult survivors of cancer: An American Society of Clinical oncology clinical practice guideline adaptation","volume":"32","author":"Bower","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0043","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2019.03.020","article-title":"Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: evolution of practice from EMBRACE-I to II","volume":"104","author":"Berger","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0044","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/ecco-jcc\/jjz024","article-title":"Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: A multicentre study","volume":"13","author":"Chavarr\u00eda","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2017.07.039","article-title":"Sleep disturbance and fatigue are associated with more severe urinary incontinence and overactive bladder symptoms","volume":"109","author":"Ge","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0047","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1470-2045(03)01191-4","article-title":"Effects of radiation on normal tissue: Consequences and mechanisms","volume":"4","author":"Stone","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0048","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.3747\/co.20.1302","article-title":"A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue","volume":"20","author":"Howell","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0049","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.022_bib0050","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162103220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162103220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:58:40Z","timestamp":1759744720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162103220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S036030162103220X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}